<DOC>
	<DOC>NCT00097786</DOC>
	<brief_summary>This study is a test of the safety and effectiveness of two drugs, one for diabetes and one for hypertension, in keeping patients with high lab values of glucose from progressing to frank diabetes and developing cardiovascular complications. People in this study cannot have frank diabetes but are considered "borderline" based on blood tests. People in the study take none, one or both of the drugs and do not know which one(s) they are taking.</brief_summary>
	<brief_title>Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Nateglinide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Adults Impaired glucose tolerance Age dependent risk factors Frank diabetes For detailed information, call contact person.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Prevention</keyword>
	<keyword>Diabetes type 2</keyword>
	<keyword>valsartan</keyword>
	<keyword>nateglinide</keyword>
</DOC>